PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Gabriela de Oliveira

Universidade Estadual de Campinas (UNICAMP)

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · JOURNAL ARTICLE

Clinical and translational profiling of oncotherad (MRB-CFI-1) nanoimmunotherapy identifies HER-2/SERBP1–associated recurrence and HABP4/IFN-γ–associated disease control in pT1 non-muscle-invasive bladder cancer after BCG failure

Journal of Cancer Research and Clinical Oncology

Single-center retrospective cohort of 21 patients with identified biomarkers and clinical outcomes, but lacking prospective validation, control group, and adequate power to establish causality or guide practice.

PromisingAndré da Silva Santos Gabriela de Oliveira Wagner José Fávaro

Reported

Sample size21

Pathological complete response ra…71.4%

Mean recurrence-free survival21.2 months

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support